Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

Tue, 30th Nov 2021 19:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Zambeef Products PLC - Zambia-focused cold chain foods and retail business - Generates pretax profit for the year ended September 30 of ZMW204.0 million, or around USD9.7 million, swinging from a ZMW22.7 loss the year before. Revenue is up 28% at ZMW4.97 billion from ZMW3.88 billion the prior year. Attributes "sustained consumer demand" for products for the positive trading performance. Notes an inflationary environment, with management continuing to focus on cost control measures which ensured administration and distribution expenses were contained within inflationary levels and only increased by 20%. "Despite the rising input costs and rising global food prices, and a difficult operating environment resulting from the 2020 economic and Covid-19 pandemic related uncertainties, the positive full year performance has been driven by sustained consumer demand for our products and cost reductions and efficiency improvements especially in the poultry business. The macroeconomic fundamentals remained relatively stable during the financial year in the context of the previous comparative year," explains Chief Executive Walter Roodt.

----------

Altitude Group PLC - Sheffield-based firm operating a marketplace for personalised products - Revenue for half-year to September 30 rises 33% to GBP5.9 million from GBP4.4 million year-on-year, leading to narrowed pretax loss of GBP414,000 from GBP1.3 million. Notes investments have helped to grow US service revenue by 34% in the period to GBP2.2 million and overall service revenue by 26% to GBP2.8 million. The Sheffield-based firm says it continues to trade positively and current performance is in line with internal expectations. "With ongoing investment in growth, strong focus on core business development and sustained recovery the board is optimistic and expects continued profitability in the full year," says Chief Executive Nichole Stella.

----------

ReNeuron Group PLC - Bridgend, Wales-based exosome therapeutics company - Narrows pretax loss for the first half ended September 30 to GBP6.0 million from GBP8.0 million year before, boosted by reduced costs incurred in the period. Revenue inches up to GBP58,000 from GBP41,000 year prior. Notes early data from the company's programme in retinitis pigmentosa, is expected in late first quarter 2022 and following analysis of data, the company will decide on the next steps to progress the programme to the next stage. Chief Executive Olav Hellebo says: "Exosomes are becoming an increasingly exciting method for delivering payloads into patients and we are therefore optimistic that we can increase the number of partnerships in this area while continuing to progress our current collaborations toward the clinic. We feel we are in the right place, at the right time, with the right technology to be a leader in exosomes."

----------

Watchstone Group PLC - cash shell with remaining assets comprising litigation assets, contingent liabilities and cash - Files GBP13.7 million claim against KPMG for the financial services behemoth's audit of Watchstone. The claim relates to an unqualified audit report in respect of the 2013 audit made by KPMG and a subsequent GBP4.5 million fine made by the Financial Reporting Council after an investigation by the watchdog. Watchstone says it suffered a loss in the sum of GBP13.7 million which it now claims in damages from KPMG for its failings.

----------

Fulcrum Utility Services Ltd - Sheffield-based utility infrastructure and services - Announces it is progressing well with sale of domestic customer gas connection assets and associated meters to ES Pipelines Ltd. Fulcrum has now completed the transfer of the fourth tranche of the assets to ESP for GBP2.8 million. Cash of GBP2.7 million was received on Tuesday with the remainder expected to be received on May 31. The total consideration receivable by Fulcrum is expected to be around GBP49 million.

----------

Nanoco Group PLC - Manchester-based quantum dots developer - Reports first quarter trading in line with internal expectations. "We continue to deliver R&D services under a number of contracted development programmes with different customers in the sensing market, which include the additional work package for our European customer announced on 5 November. Good progress has been made on these projects during the period and discussions on potential next steps are underway," company says.

----------

Silver Bullet Data Services Group PLC - London-based marketing services firm - Signs contract for its 4D product with Paris-based consulting group CoSpirit Mediatrack. 4D will now be the preferred partner for CoSpirit in relation to "contextual solutions, supporting its clients' migration from the utilisation of third-party cookies to first-party-driven data contextual insights and targeting", Silver Bullet highlights. Chief Executive Ian James states: "As part of our drive for the continued integration of our 4D solution with media agency platforms, we are delighted to be partnering with one of the best and fastest growing media agencies in France, an ideal partner for the application of our 4D product".

----------

Sensyne Health PLC - Oxford-based healthcare technology company - Agrees settlement terms with the London Stock Exchange for a public censure and fine of GBP580,000, discounted to GBP406,000 for early settlement. The fine relates to historical breaches of AIM rules in relation to the payment of certain IPO bonuses in 2018.

----------

Northcoders Group PLC - Manchester, England-based training programmes provider - Signs contract for a new training hub in Newcastle in line with its national expansion plans. The new site is part of the innovation hub TusPark, Barclays Eagle Labs, Newcastle. Chief Executive Chris Hill comments: "The TusPark site is a well-regarded centre of innovation and excellence in the north of England and we are excited to be part of this new and growing community."

----------

Nanosynth Group PLC - digital monitoring and safeguarding systems manufacturer - In strategy update, says it is now focused on the development of its nanomaterials technology around Pharm2Farm. Is considering relocating operations in 2022 to new UK facility that may include a scalable state-of-the-art production facility for nanomaterials. Says anti-viral technology remains a key area of focus and it is establishing network of distributors to supply masks and other products which include this technology. "A thorough assessment of the company's in-house technology and R&D pipeline has identified eight market sectors where we can either manufacture products ourselves or work in partnerships where the partners' IP, manufacturing capability, routes to market or other capabilities can be enhanced using our in-house skills or technology," company states.

----------

Ideagen PLC - information management, safety, risk and compliance software provider - Outlines new targets for next three years. Targetting recurring revenue of GBP200 million by April 2025 and 15% year-on-year organic growth. "Twelve years of profitable growth, underpinned by our talented team and strong working culture, give us confidence that we can accelerate our growth and achieve the target GBP200 million ARR by April 2025. We look forward to building on our achievements to date and delivering against our ambitious medium-term targets," comments Chief Executive Ben Dorks.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based bio-pharmaceutical company - Completes GBP5.5 million share placement with "strong support from UK institutional investors and a US based fund". The shares will be issued at a price of 2 pence each, representing a 13% discount from the closing price on 29 November, being the last practicable trading day. The shares will represent approximately 10% of shares in issue.

----------

Goldstone Resources Ltd - gold explorer in West Africa - Completes first commercial gold pour at the Homase Mine in the Ashanti Gold Belt in Ghana. The production now enables the company to meet interest payment for the USD3 million secured gold loan with Asia Investments Management Services. "Now that we have managed to successfully complete the transition into a gold producer, we will focus our efforts on ramping up the project to full operations as efficiently as possible, by continuing ramp-up of stacking to the Heap Leach and optimisation of the processing plant," comments Chief Executive Emma Priestley.

----------

Octopus Renewables Infrastructure Trust PLC - UK-based closed-ended investor in renewable energy assets - Enters 10-year power purchase agreement for Ljungbyholm Wind Farm in Sweden. Notes the unnamed counterparty is a "global manufacturer with a multi-billion dollar valuation". The contract provides Ljungbyholm with a 10-year floor price for all of its production each year, and will provide the offtaker with green electricity for its operations in Sweden as part of its ambitions to switch to 100% renewable electricity by 2030.

----------

Condor Gold PLC - mine developer in Nicaragua - Completes drilling for feasibility study at La India gold project in Nicaragua. Analysis of rock mass units on core samples is underway, Condor highlights. "A combined 32 geotechnical drill holes for 3,251.50 metres has been completed on La India open pit providing sufficient data for FS level design pit angles for the pit over the life of mine," company says.

----------

Bezant Resources PLC- copper-gold exploration and development company - Mobilises rig to drill and test several targets near Hope and Gorob copper-gold deposits in Namibia. Also commences work in preparation for a mining licence application over the Hope-Gorob copper-gold project area, Bezant states. Executive Chair Colin Bird comments: "We consider Namibia a very supportive jurisdiction and we are doing all necessary to progress plans for a mining application at Hope-Gorob. We are excited about the planned drilling programme - we have an already established resource and the geophysics suggests the potential to mirror that resource. A drill rig is on site and we look forward to reporting on progress as the programme advances."

----------

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
1 Sep 2022 17:52

TRADING UPDATES: Strong interim results from Johnson Service, Eurocell

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Aug 2022 11:57

IN BRIEF: Graft Polymer wins first commercial order for GraftBio

Graft Polymer (UK) PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Wins first commercial purchase order for its GraftBio division. Order for 50,000 units of its anti-inflammatory supplement, ArtemiC Rescue from MGC Pharmaceuticals PLC. Order worth around USD1 million. Production to start immediately. Delivery expected over the next three months. Chief Executive Victor Volduev says he expects follow-on orders in the coming quarters.

Read more
17 Aug 2022 11:12

MGC shares rise on USD1 million order for ArtemiC

(Alliance News) - MGC Pharmaceuticals Ltd shares were lifted on Wednesday after it announced a USD1 million order for its neutraceutical, ArtemiC.

Read more
15 Aug 2022 17:31

IN BRIEF: MGC Pharma's CannEpil found safe for driving in study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says clinical study results for its epilepsy treatment, CannEpil, are complete. The study found CannEpil to be safe for post-treatment driving activities. It used a driving simulator to test whether the drug caused somnolence, ie drowsiness, or impairs cognition. It was sponsored by Cannvalate Australia, and conducted by the Centre of Human Psychopharmacology at Swinburne University of Technology, under the Medical Cannabis Research Collaboration.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
29 Jul 2022 19:36

TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Jul 2022 21:53

IN BRIEF: MGC Pharmaceuticals quarterly sales "strong"

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says "strong" quarterly sales continue, notes AUD1.6 million, about GBP923,000, in cash receipts during three month period to June 30. In 12-month period, records AUD6.1 million in cash receipts.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
8 Jul 2022 14:19

IN BRIEF: MGC Pharmaceuticals wins approval for Covid study, shares up

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives approval from South African Health Products Regulatory Authority for a Phase 2b dose finding study of its nanoparticle formulation CimetrA on patients diagnosed with Covid-19.

Read more
6 Jul 2022 20:08

IN BRIEF: MGC Pharmaceuticals launches medical data app ZAM

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says it is set to launch a real-time data collection application, ZAM, for use across the pharmaceutical and health care sectors, in collaboration with software development company, Caba Tech. The app will be available during the third quarter and will enable patients to log their medical history and monitor their medication use. ZAM, through the collection the patient data, will also provide users with a more complete understanding of their health and treatments, it says.

Read more
27 Jun 2022 20:27

IN BRIEF: MGC's CimetrA shows promise beyond Covid applications

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says preliminary results from pre-clinical in vitro study of CimetrA show it could have "wide-ranging application" as anti-inflammatory treatment. This is through the treatment's modulation of the production of pro-inflammatory cytokines. The study was undertaken by Israeli contract research organisation, Science in Action. Results support previous findings from a 2020 study into Covid-19, which showed CimetrA modulates the body's production of cytokines, which can lead to a cytokine storm, a type of severe immune reaction. New results support the potential of CimetrA to have a wider-ranging application as anti-inflammatory treatment, beyond the treatment of Covid-19 symptoms.

Read more
24 Jun 2022 10:13

IN BRIEF: MGC Pharma moves ahead with Covid-19 treatment in US

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Progresses plans to begin US clinical trial for its Covid-19 treatment CimetrA, as MGC and AMC Holdings Inc executives meet with department heads from the University of South Florida. Parties also discuss regulatory approvals for phytocannabinoid medicines CogniCann and CannEpil in the US for early patient access schemes. Says US market access and distribution agreement has been signed with minimum orders of USD24 million over three years, including CimetrA.

Read more
16 Jun 2022 13:43

IN BRIEF: MGC Pharmaceuticals completes research study on brain cancer

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes an in-vitro preclinical research study with the National Institute of Biology into the use of cannabinoids to treat brain cancer. The company says the study, undertaken on 30 biopsy samples from 18 patients over a period of three years, sought to determine the optimal formulation for the treatment of Glioblastoma, a form of brain cancer. The study showed that MGC Pharma's proprietary formulations were cytotoxic to Glioblastoma tumour and stem cells, reducing the cells' viability and inducing caspase-dependent cell apoptosis, or cell death.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.